Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Taro Receives Final FDA Approval for Carbamazepine Extended-Release Tablets
Taro Pharmaceuticals USA, 04/06/09
Taro Pharmaceutical Industries Ltd. reported that it received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg and 400 mg.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/15/09
Article Search
Sponsor